CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Open-market sale Chief Legal Officer sold 1,513 shares at $12.04 ($18,220)
- 4 Planned sale Chief Financial Officer sold 6,812 shares at $10.02 ($68,223)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 1,671 shares at $7.99 ($13,352)
- 4 Open-market sale Chief Scientific Officer sold 2,334 shares at $7.99 ($18,649)
- 4 Open-market sale Chief Legal Officer sold 1,760 shares at $7.99 ($14,063)
- 4 Planned sale Chief Financial Officer sold 3,541 shares at $10.00 ($35,421)
- 4 Planned sale Chief Financial Officer sold 10,906 shares at $10.00 ($109,093)
- 4 Open-market sale Chief Financial Officer sold 1,080 shares at $5.20 ($5,613)
- 4 Open-market sale Chief Legal Officer sold 1,232 shares at $5.20 ($6,403)
- 4 Open-market sale Chief Scientific Officer sold 1,633 shares at $5.20 ($8,487)
- 4 Open-market sale Chief Financial Officer sold 1,245 shares at $9.65 ($12,020)
- 4 Open-market sale General Counsel sold 1,420 shares at $9.65 ($13,710)
- 4 Open-market sale Chief Scientific Officer sold 1,884 shares at $9.65 ($18,189)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 14 · 274 filings